Predictors of re-bleeding after endoscopic hemostasis for delayed post-endoscopic sphincterotomy bleeding

Table 1 Associations between re-bleeding and patient characteristics n (%)

	Re-bleeding	No re-bleeding	P value
	(n = 35)	(n = 126)
Age (yr)	63.0 (52.0-70.0)	57.0 (46.5-71.0)	0.121
Sex (male)	23 (65.7)	82 (65.1)	0.944
White blood cell count (× 103/μL)	8.1 (5.6-10.0)	8.1 (6.0-10.7)	0.673
Platelet count (× 103/μL)	225 (122-262)	215 (160-268)	0.320
INR	1.1 (1.0-1.5)	1.1 (1.0-1.2)	0.075
Total bilirubin (mg/dL)	10.9 (2.3-22.3)	6.5 (1.1-15.8)	0.002
ESRD	3 (8.6)	10 (7.9)	1.000
Decompensated liver cirrhosis	4 (11.4%)	4 (3.2)	0.047
Use of anti-platelet regimen
Before ES	3 (8.6)	3 (2.4)	0.117
Within 3 d after ES	2 (5.7)	2 (1.6)	0.206
Cholangitis before ES	13 (37.1)	58 (46.0)	0.349
Bleeding diathesis	16 (45.8)	22 (17.5)	< 0.001

ESRD: End stage renal disease; INR: International normalized ratio; ES: Endoscopic sphincterotomy.